FWBI Stock Earnings: First Wave BioPharma Reported Results for Q1 2023

Source: iQoncept / Shutterstock

First Wave BioPharma (NASDAQ:FWBI) just reported results for the first quarter of 2023.

  • First Wave BioPharma reported earnings per share of -$36.40.
  • The company did not report any revenue for the quarter.

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.


Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2023/12/fwbi-stock-earnings-first-wave-biopharma-for-q1-of-2023/.

©2023 InvestorPlace Media, LLC

Source link

Share with your friends!

Leave a Reply

Your email address will not be published. Required fields are marked *

Please enter CoinGecko Free Api Key to get this plugin works.

Get The Latest Investing News
Straight to your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.